Caredx demonstrates global leadership at 29th international congress of the transplantation society

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna) – the transplant company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced its leading participation in the 29th international congress of the transplantation society (tts 2022) taking place september 10-14 in buenos aires, argentina. transplant physicians will present data from over 25 abstracts demonst
CDNA Ratings Summary
CDNA Quant Ranking